Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings

Addiction

Volumn 107, Issue 5, 2012, Pages 943-952

  Schwartz, Robert P ^a   Kelly, Sharon M ^a   O'Grady, Kevin E ^b   Gandhi, Devang ^c   Jaffe, Jerome H ^a,c  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Counseling; Heroin addiction treatment; Interim methadone; Methadone treatment; Opiate agonist treatment; Opiate dependence

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADULT; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; COCAINE-RELATED DISORDERS; COUNSELING; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 84859362223     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03700.x     Document Type: Article

References (31)

1. World Health Organization (WHO). WHO Prisons and Health Facts and Figures. Denmark: WHO; 2011. Available at: (accessed 19 April 2011; archived by Webcite at).
2. Clausen T., Anchersen K., Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend 2008; 94: 151-7.
3. Degenhardt L., Randall D., Hall W., Law M., Butler T., Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend 2009; 105: 9-15.
4. Gibson A., Degenhardt L., Mattick R. P., Ali R., White J., O'Brien S. Exposure to opioid maintenance treatment reduces long-term mortality. Addiction 2008; 103: 462-8.
5. Mattick R. P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; 3: CD002209.
6. Gossop M., Grant M. A six country survey of the content and structure of heroin treatment programmes using methadone. Br J Addict 1991; 86: 1151-60.
7. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual Report: The State of the Drugs Problem in Europe. Portugal: EMCDDA; 2010. Available at: (accessed 7 April 2011; archived by Webcite at).
8. World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, Switzerland: World Health Organization Press; 2009.
9. Rettig R. Chapter 5: Federal regulation of methadone treatment. In: Rettig R. A., Yarmolinsky A., editors. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press; 1995, p. 129-32.
10. Farrell M., Ward J., Mattick R., Hall W., Stimson G. V., des Jarlais D. etal. Methadone maintenance treatment in opiate dependence: a review. BMJ 1994; 309: 997-1001.
11. Drug Abuse Treatment Act. Drug Addiction Treatment Act of 2000, SEC. 3502. Amendment to Controlled Substance Act. Rockville, MD: US Department of Health and Human Services; 2000.
12. Calsyn D. A., Wells E. A., Saxon A. J., Jackson T. R., Wrede A. F., Stanton V. etal. Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome. J Addict Dis 1994; 13: 47-63.
13. Gruber V. A., Delucchi K. L., Kielstein A., Batki S. L. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend 2008; 94: 199-206.
14. Senay E. C., Jaffe J. H., diMenza S., Renault P. F. A 48-week study of methadone, methadyl acetate and minimal services. In: Fisher S., Freeman A., editors. Opiate Dependence: Origins and Treatment. New York: Halstead Press; 1973, p. 185-201.
15. McLellan A. T., Arndt I. O., Metzger D. S., Woody G. E., O'Brien C. P. The effects of psychosocial services in substance abuse treatment. JAMA 1993; 269: 1953-9.
16. Yancovitz S. R., Des Jarlais D. C., Peyser N. P., Drew E., Friedmann P., Trigg H. L. etal. A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991; 81: 1185-91.
17. Federal Register. Title 21, Codified at 58 CFR §495, pt 291. U.S.A. 1993.
18. Schwartz R. P., Highfield D. A., Jaffe J. H., Brady J. V., Butler C. B., Rouse C. O. etal. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry 2006; 63: 102-9.
19. Schwartz R. P., Jaffe J. H., Highfield D. A., Callaman J. M., O'Grady K. E. A randomized controlled trial of interim methadone maintenance: 10-month follow-up. Drug Alcohol Depend 2007; 86: 30-6.
20. Amato L., Minozzi S., Davoli M., Vecchi S., Ferri M. M., Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2008; 4: CD004147.
21. Schwartz R. P., Kelly S. M., O'Grady K. E., Gandhi D., Jaffe J. H. Interim methadone treatment compared to standard methadone treatment: 4-month findings. J Subst Abuse Treat 2011; 41: 21-9.
22. McLellan A. T., Kushner H., Metzger D., Peters R., Smith I., Grissom G. etal. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199-213.
23. Carroll K. M., Rounsaville B. J., Nich C., Gordon L. T., Wirtz P. W., Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994; 51: 989-97.
24. McLellan A. T., Woody G. E., Luborsky L., Goehl L. Is the counselor an 'active ingredient' in substance abuse rehabilitation? An examination of treatment success among four counselors. J Nerv Ment Dis 1988; 176: 423-30.
25. Stitzer M. L., Iguchi M. Y., Felch L. J. Contingent take-home incentive: effects on drug use of methadone maintenance patients. J Consult Clin Psychol 1992; 60: 927-34.
26. McCarty D., Perrin N. A., Green C. A., Polen M. R., Leo M. C., Lynch F. Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan. Drug Alcohol Depend 2010; 111: 235-40.
27. Petry N. M., Roll J. M., Rounsaville B. J., Ball S. A., Stitzer M., Peirce J. M. etal. Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? J Consult Clin Psychol 2008; 76: 1076-82.
28. Reisinger H. S., Schwartz R. P., Mitchell S. G., Peterson J. A., Kelly S. M., O'Grady K. E. etal. Premature discharge from methadone treatment: patient perspectives. J Psychoact Drugs 2009; 41: 285-96.
29. Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs[Treatment Improvement Protocol (TIP) Series 43. DHHS Publication No. (SMA) 05-4048]. Rockville, MD: Substance Abuse and Mental Health Services; 2005.
30. Woody G. E., Kane V., Lewis K., Thompson R. Premature deaths after discharge from methadone maintenance: a replication. J Addict Med 2007; 1: 180-5.
31. Zanis D. A., Woody G. E. One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend 1998; 52: 257-60.